Lannett intros generic ConcertaMethylphenidate hydrochloride ER tablets had a market value of about $1.4 billion for the 12 months ended February 2019, according to IQVIA. Contract Pharmacal acquires Florida Pharmaceutical ProductsContract Pharmacal's investment in Florida Pharmaceutical Products solidifies its entrance into the generic market. Mallinckrodt to spin off specialty generics business The separation will create one company focused on specialty branded pharmaceuticals, and another focused on specialty generic products and APIs manufacturing. Sandoz launches generic Faslodex Faslodex (fulvestrant injection) had a market value of roughly $541 million for the 12-month period ended March 2019. Glenmark's generic Aggrenox gets FDA nod Aggrenox capsules had a market value of roughly $165.6 million for the 12 months ended March 2019. Dr. Reddy's relaunches generic Accutane Isotretinoin capsules had a brand and generic market value of roughly $525 million for the most recent 12 months ended in March 2019. Teva launches generic Ranexa Ranolazine extended-release tablets had a market value of about $938 million, according to IQVIA data. Zydus gets FDA nod for generic Nexium Zydus Cadila's generic Nexium will be available in 25-mg and 40-mg dosage strengths. Perrigo's generic Voltaren gets FDA approval Voltaren gel had a market value of about $350 million for the 12 months ending March 2019. Lupin launches generic Pulmicort Respules Budesonide inhalation suspension in single-dose ampules had a market value of roughly $385.4 million, according to IQVIA March 2019 data. First Previous 187 188 189 190 191 Next Last
